Cadila Healthcare Share Price Rallies After Receiving FDA Boost – Shares of the drugmaker rose as much as 3.8 percent to Rs 363.10.
The pharmaceutical company received a green signal from the U.S drug regulator Clindamycin Phosphate Topical Solution, used to treat acne, according to its stock exchange filing.